A Monash University team has won a $1 million grant to develop an inhalable oxytocin treatment for post-partum haemorrhage, a leading cause of death in emerging markets. [ + ]

A workshop for the development of natural medicines from the Muricidae family of sea snail will be conducted at Southern Cross University (SCU) this week. [ + ]

Deborah Middleton, Senior Veterinary Pathologist at CSIRO, explains how she and her team developed the groundbreaking vaccine for the deadly Hendra virus. [ + ]

AusBiotech yesterday announced the election of a new member to its board of directors following the national biotechnology organisation’s annual general meeting, held at the national conference in Melbourne. [ + ]

Vaxxas, a UniQuest start-up established in 2011 to commercialise the Nanopatch vaccine delivery system based on research from The University of Queensland (UQ), has won the Janssen 2012 AusBiotech Emerging Company Award. [ + ]

EMD Millipore and Sistemic are jointly developing a monitoring methodology utilising Sistemic’s microRNA marker detection capability to enable consistent growth of stem cells in EMD Millipore’s Mobius CellReady platform. [ + ]

Cancer researcher, Professor Mark Shackleton, has been awarded the Science Minister’s Prize for Life Scientist of the Year for his work understanding the nature of cancer. [ + ]

Pharmaceutical industry and policy expert, Michelle Burke, has joined the AusBiotech board, as Dr Paul Walton and Dr Peter Isdale AM depart. [ + ]

Patrys (ASX:PAB) has secured ethics approval to add an Australian site to its planned phase I/IIa trial of cancer drug candidate PAB-SM6 for multiple myeloma. [ + ]

The disparity between money invested in medical discoveries compared to commercialisation is akin to investing in mining exploration and nothing else, says Dr Jurgen Michaelis, Executive Director of newly launched Verde Capital, a venture capital fund. [ + ]

The gap between applying for marketing approval and receiving the go-ahead from regulators is the real ‘valley of death’ facing biotechs, says Alan Robertson, CEO of Pharmaxis. [ + ]

Starpharma, Vaxxas, Dr Andrew Baker and Connor O’Meara all received awards at the AusBiotech 2012 conference in Melbourne last night. [ + ]

Two giant advertising billboard signs have been given over to exhibit a piece of art based on a vital but little-known physics equation. [ + ]

Professor Ken Freeman has received the $300,000 Prime Minister’s Prize for Science for almost 50 years’ work shaping and changing the human view of galaxies and the universe. [ + ]

Health regulators need a radical overhaul if the “innovation gap” between research and health care is to be bridged in the future, says Dr Richard Barker. [ + ]